Follow
Ali Attiq, PhD
Title
Cited by
Cited by
Year
Raging the war against inflammation with natural products
A Attiq, J Jalil, K Husain, W Ahmad
Frontiers in pharmacology 9, 412989, 2018
1902018
New insights into molecular mechanism behind anti-cancer activities of lycopene
BP Puah, J Jalil, A Attiq, Y Kamisah
Molecules 26 (13), 3888, 2021
712021
The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19
A Attiq, LJ Yao, S Afzal, MA Khan
International immunopharmacology 101, 108255, 2021
692021
Annonaceae: breaking the wall of inflammation
A Attiq, J Jalil, K Husain
Frontiers in pharmacology 8, 752, 2017
512017
Luteolin and apigenin derived glycosides from Alphonsea elliptica abrogate LPS-induced inflammatory responses in human plasma
A Attiq, J Jalil, K Husain, HF Mohamad, A Ahmad
Journal of ethnopharmacology 275, 114120, 2021
292021
The medicinal uses, toxicities and anti-inflammatory activity of Polyalthia species (Annonaceae)
LJ Yao, J Jalil, A Attiq, CC Hui, NA Zakaria
Journal of ethnopharmacology 229, 303-325, 2019
292019
Modulation of inflammatory pathways, medicinal uses and toxicities of Uvaria species: potential role in the prevention and treatment of inflammation
J Jalil, A Attiq, CC Hui, LJ Yao, NA Zakaria
Inflammopharmacology 28, 1195-1218, 2020
142020
Antibacterial activity of essential oils extracted from medicinal plants against multi-drug resistant Staphylococcus aureus.
SA Raja, M Ashraf, AA Anjum, A Javeed, T Ijaz, A Attiq
122016
Enhancement of anti-proliferative activities of Metformin, when combined with Celecoxib, without increasing DNA damage
A Ullah, M Ashraf, A Javeed, AA Anjum, A Attiq, S Ali
Environmental toxicology and pharmacology 45, 227-234, 2016
102016
Antioxidant Potential of Adiponectin and Full PPAR-γ Agonist in Correcting Streptozotocin-Induced Vascular Abnormality in Spontaneously Hypertensive Rats
S Afzal, MA Sattar, EJ Johns, OA Eseyin, A Attiq
PPAR research 2021, 2021
62021
Hegemony of inflammation in atherosclerosis and coronary artery disease
A Attiq, S Afzal, W Ahmad, M Kandeel
European journal of pharmacology, 176338, 2024
52024
From imbalance to impairment: the central role of reactive oxygen species in oxidative stress-induced disorders and therapeutic exploration
S Afzal, AS Abdul Manap, A Attiq, I Albokhadaim, M Kandeel, SM Alhojaily
Frontiers in Pharmacology 14, 1269581, 2023
52023
A new prenylated benzoquinone from Cyathocalyx pruniferus abrogates LPS-induced inflammatory responses associated with PGE2, COX-2 and cytokines …
A Attiq, J Jalil, K Husain, JA Jamal, EN Ismail
Inflammopharmacology 29, 841-854, 2021
52021
Crosstalk relationship between adiponectin receptors, PPAR-γ and α-adrenoceptors in renal vasculature of diabetic WKYs
S Afzal, MA Sattar, OA Eseyin, A Attiq, EJ Johns
European journal of pharmacology 917, 174703, 2022
32022
Trinity of inflammation, innate immune cells and cross-talk of signalling pathways in tumour microenvironment
A Attiq, S Afzal
Frontiers in pharmacology 14, 1255727, 2023
22023
Augmented cytotoxic, mutagenic and genotoxic response triggered by carvedilol and celecoxib combinations
A Attiq, M Ashraf, J Jalil, A Javeed, AA Anjum, A Ullah, M Umair, S Ali
Brazilian Journal of Pharmaceutical Sciences 54, e17292, 2018
22018
Platinum-Based Targeted Chemotherapies and Reversal of Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC)
H Umar, HA Wahab, A Attiq, MW Amjad, SNA Bukhari, W Ahmad
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 111856, 2024
2024
Full PPAR-γ Agonist With Adiponectin Abrogates Oxidative Stress.
S Afzal, MA Sattar, A Attiq, A Velaga
Malaysian Journal of Medicine & Health Sciences 18, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–18